FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Methods are described associated with regenerative medicine, for the treatment of lesions of cartilage, osteoarthritis and cartilage damage, in particular. FGF-18 compound is described for use in tissue engineering and transplantation procedures, such as bone cartilage or cartilage grafts, or autologous chondrocyte implantation (ACI).
EFFECT: compound FGF-18 has a beneficial effect on three-dimensional cultures.
11 cl, 11 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMPLANT CONTAINING FGF-18 | 2015 |
|
RU2700414C2 |
| 3D IN VITRO TWO-PHASE OSTEOCHONDRAL CONSTRUCT | 2013 |
|
RU2615439C2 |
| APPLICATION OF CXCL6 CHEMOKINE DURING PREVENTION OR ELIMINATION OF CARTILAGE DEFECTS | 2004 |
|
RU2363491C2 |
| METHOD OF PRODUCING CARTILAGE-LIKE STRUCTURES FROM STEM CELLS WITH INDUCED PLURIPOTENCY AND STRUCTURES OBTAINED USING SAID METHOD | 2023 |
|
RU2814248C1 |
| NEW PEPTIDE AND ITS APPLICATION | 2011 |
|
RU2525913C1 |
| SCHEME FOR USING FGF-18 COMPOUND | 2015 |
|
RU2700582C2 |
| SCHEME FOR USING FGF-18 COMPOUND | 2015 |
|
RU2691946C2 |
| MULTI-DIMENSIONAL BIOMATERIAL AND METHOD FOR PREPARING IT | 2010 |
|
RU2542430C2 |
| MARKER GENES USED TO IDENTIFY PHENOTYPIC STABILITY OF CHONDROCYTES AND TO SCREEN CARTILAGE PRODUCTION FACTORS | 2007 |
|
RU2508548C2 |
| METHOD FOR OBTAINING TISSUE-ENGINEERED PERICHONDRIUM TRANSPLANT BASED ON CELL SPHEROIDS | 2022 |
|
RU2807692C2 |
